The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience

Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)

(2016) Lili Liu et al.   Oncotarget

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer: A Phase II Study from a Chinese Center

(2014) Chao-Qun Huang et al.   PLoS One

Laparoscopic Hyperthermic Intraperitoneal Chemotherapy: Indications, Aims, and Results: A Systematic Review of the Literature

(2012) Enrico Facchiano et al.   ANNALS OF SURGICAL ONCOLOGY

The Role of Laparoscopy in Peritoneal Surface Malignancies Selected for Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

(2012) Antonio Sommariva et al.   ANNALS OF SURGICAL ONCOLOGY

Malignant ascites: pathophysiology and treatment

(2012) Emanuel Cavazzoni et al.   International Journal of Clinical Oncology

Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

(2012) Paul H Sugarbaker et al.   LANCET ONCOLOGY